Infection, vaccination, and childhood arterial ischemic stroke
Results of the VIPS study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 26, 2015
- Accepted in final form June 15, 2015
- First Published September 30, 2015.
Article Versions
- Previous version (September 30, 2015 - 13:00).
- Previous version (October 21, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Heather J. Fullerton, MD, MAS,
- Nancy K. Hills, PhD,
- Mitchell S.V. Elkind, MD, MS,
- Michael M. Dowling, MD, PhD,
- Max Wintermark, MD,
- Carol A. Glaser, DVM, MD,
- Marilyn Tan, MD,
- Michael J. Rivkin, MD,
- Luigi Titomanlio, MD, PhD,
- A. James Barkovich, MD and
- Gabrielle A. deVeber, MD, MSc
- On behalf of the VIPS Investigators
- Heather J. Fullerton, MD, MAS,
I serve on a DSMB for the NIH for clinical trials related to sickle cell disease and stroke.
NONE
NONE
Stroke, member of editorial board, beginning 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
R01 NS062820HJ (PI) NIH/NINDS Vascular Effects of Infection in Pediatric Stroke (VIPS) 08/05/2009 - 07/31/2015; NIH/NINDS - U54 - Stroke NETT - Principal Investigator - 08/01/2014 - 07/31/2018 NIH/NINDS - U01 - Stroke in the Young - Principal Investigator - 07/01/2014 - 07/31/2018 R01 NS062820-02S1(PI) NIH/NINDS Global Health Supplement to VIPS 08/01/2010 - 07/31/2011; K02 NS053883(PI) NIH/NINDS Independent Scientist Award The Role of Infection in Childhood Stroke 06/01/2006 - 08/31/2011 R01 HL096789-01RJ (Co-investigator) NIH/HSOD Prevention of Stroke after STOP (POST-STOP) 07/01/2009 - 06/30/2015
NONE
American Heart Association Established Investigator Award
NONE
NONE
NONE
NONE
NONE
NONE
- Nancy K. Hills, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Thrasher Research Foundation RAS-A116619 2/1/11-1/31/13 (no-cost extension until 1/31/14) Stimulants and Childhood Stroke (StaCS) This is a case-control study nested within the cohort of the 2.5 million children enrolled in KPMCP from 1993-2007 with the goal of determining whether ADHD medications increase the risk of childhood arterial ischemic stroke. Role: PI
NONE
NONE
NONE
NONE
NONE
NONE
- Mitchell S.V. Elkind, MD, MS,
(1) Boehringer-Ingelheim, Inc., anticoagulants and stroke (2014-2015); (2) BMS-Pfizer Partnership,anticoagulants and stroke (2014-2015); (3) Daiichi-Sankyo, anticoagulants and stroke (2013-2014); (4) Janssen Pharmaceuticals, anticoagulants and stroke (2013-2014); (5)Biogen IDEC, natalizumab and stroke (2013); (6) Biotelemetry/Cardionet, monitoring for atrial fibrillation after stroke (2014)
NONE
NONE
(1) Neurology, Resident and Fellow Section editor, published by American Academy of Neurology (2007-2015)
NONE
UpToDate, 2015, chapters on cryptogenic stroke and hemicraniectomy for acute stroke
NONE
(1) BMS-Pfizer Partnership, consultant regarding antithrombotics for stroke (2014)
NONE
(1) American Heart Association National Board of Directors (2014-2016); (2) American Heart Association Founders Affiliate Board of Directors(2008-2013); (2) American Heart Association NY City Board of Directors (2011-2015)
NONE
(1) diaDexus, Inc: funding for biomarker research; (2) BMS-Sanofi Pharmaceutical Partnership: funding for biomarker research
(1) NIH/NINDS R37 29993, PI, 2007-2020, (2) NIH/NINDS P50 NS049060, Project 1, PI, NeuSTART, 2004-2016
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Organon/Merck, NuvaRing and stroke litigation, 2009-2015
- Michael M. Dowling, MD, PhD,
NONE
NONE
NONE
Editorial Board Member for the Journal of Child Neurology
NONE
NONE
I received honoraria for speaking at a board review course
NONE
NONE
NONE
I am a Pediatric Neurologist and I see children with stroke.
NONE
NONE
First Americal Real Estate Information Services, INC Children's Clinical Research Advisory Group (Research Support)
Doris Duke Charitable Foundation (Grant)
NONE
NONE
NONE
NONE
NONE
NONE
- Max Wintermark, MD,
(1) Commercial entity: GE-NFL board
NONE
NONE
American Journal of Neuroradiology, editorial board since 2010 American Journal of Roentgenology, editorial board since 2010
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Carol A. Glaser, DVM, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marilyn Tan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael J. Rivkin, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Luigi Titomanlio, MD, PhD,
NONE
NONE
NONE
Italian Journal of PEdiatrics, Associate Editor, 2014- present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- A. James Barkovich, MD and
NONE
NONE
European Course on Pediatric Neuroradiology
American Journal of Neuroradiology Neuropediatrics
NONE
(1) Pediatric Neuroimaging, 4th Edition, Lippincott Williams & Wilkins, published 2005. 5th Edition published 2012. (2) Diagnostic Imaging: Brain, 2nd Edition, Amersys 2010
NONE
NONE
NONE
NONE
NONE
NONE
NIH/NINDS R01 NS 046432 PI, 2009-2015 NIH/NIBIB R01 HD072074 CoI, 2013-2017 NIH/NINDS P01 NS082330 PI Project 1, CoI Core B NIH/NINDS R01 NS35129 PI of Subcontract
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gabrielle A. deVeber, MD, MSc
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NINDS
NONE
The Auxilium Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (H.J.F., N.K.H., A.J.B.), Pediatrics (H.J.F., C.A.G., A.J.B.), Biostatistics and Epidemiology (N.K.H.), and Radiology (A.J.B.), University of California San Francisco; the Departments of Neurology and Epidemiology (M.S.V.E.), Columbia University College of Physicians and Surgeons and Mailman School of Public Health, New York, NY; the Departments of Pediatrics and Neurology and Neurotherapeutics (M.M.D.), UT Southwestern Medical Center, Dallas, TX; the Department of Radiology (M.W.), Stanford University, Palo Alto, CA; the Division of Communicable Disease Control (C.A.G.), Center for Infectious Diseases, California Department of Public Health, Richmond; the Departments of Pediatrics and Neurosciences (M.T.), University of the Philippines–Philippine General Hospital, Manila, Philippines; the Departments of Neurology, Psychiatry, and Radiology (M.J.R.), Boston Children's Hospital, MA; the Pediatric Emergency Department (L.T.), Robert Debré Hospital, Paris Diderot University, Paris, France; and the Department of Neurology (G.A.d.), Hospital for Sick Children, Toronto, Canada.
- Correspondence to Dr. Fullerton: Heather.Fullerton{at}ucsf.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.